Efficacy

Support for the use of COREG CR® extended-release capsules for the treatment of mild-to-severe heart failure and for patients with left ventricular dysfunction following myocardial infarction is based on the equivalence of pharmacokinetic and pharmacodynamic (β1‑blockade) parameters between COREG CR and immediate-release carvedilol. Visit DailyMed for the full Clinical Pharmacology Data.